Global single-cell multiomics market to hit $13 billion by 2030 at 21.7% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Single Cell Multiomics Market Be By 2030 Compared To Its 2026 Market Size?

The single cell multiomics market size has experienced rapid growth in recent years. Projections indicate it will expand from $4.85 billion in 2025 to $5.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.1%. This historical expansion can be primarily ascribed to breakthroughs in single-cell sequencing technologies, a surge in cancer research initiatives, increased funding within life sciences research, enhanced access to high-throughput analysis tools, and an uptick in academic research funding.

The single cell multiomics market is projected to experience rapid expansion in the coming years. This market is anticipated to reach a valuation of $13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 21.7%. The projected expansion during this period stems from several factors, including the escalating need for precision medicine applications, greater integration into clinical research processes, the proliferation of multiomics data integration platforms, increased funding for pharmaceutical research, and ongoing advancements in analytical sensitivity. Key trends anticipated within the forecast timeframe involve the wider acceptance of integrated multiomics platforms, a heightened requirement for high-resolution single-cell analysis, the increasing deployment of AI-powered data interpretation tools, the development of multi-modal cellular profiling methodologies, and a stronger emphasis on understanding cellular heterogeneity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

Which Primary Drivers Are Impacting The Single Cell Multiomics Market Growth?

The expanding requirement for precision medicine is expected to drive the growth of the single cell multiomics market in the future. Precision medicine refers to a medical approach that customizes treatment and healthcare strategies based on the individual characteristics of each patient. The rise in precision medicine is fueled by advancements in genomic research, enhanced data analysis capabilities, and a heightened understanding of personalized healthcare advantages. Single-cell multiomics provides detailed insights into cellular heterogeneity and molecular mechanisms, enabling the development of highly personalized treatments tailored to individual patients’ unique cellular profiles. For instance, in May 2025, according to the Personalized Medicine Coalition (PMC), in 2023, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines, representing about 38% of all newly approved therapeutic molecular entities. Therefore, the increasing demand for precision medicine is propelling the growth of the single cell multiomics market.

What Are The Different Segment Types In The Single Cell Multiomics Market Segment Breakdown?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

Which Trends Are Shaping Growth In The Single Cell Multiomics Market?

Leading companies within the single cell multiomics market are actively developing single-cell multiomics tests to elevate the precision and resolution of cellular analysis. These single-cell multiomics tests empower researchers to gain a clearer understanding of complex biological processes, identify rare cell populations, and customize precision medicine approaches by integrating thorough molecular data from individual cells. For example, in June 2024, Mission Bio, a US-based biotechnology company, introduced its Tapestri Single-cell Multiple Myeloma Multiomics Solution. This solution facilitates comprehensive profiling of multiple myeloma at single-cell resolution, allowing translational researchers and drug developers to fully dissect the molecular and cellular landscape during myeloid progression, understand therapy resistance, and identify drivers of disease evolution from early stages such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Who Are The Well-Known Companies In The Single Cell Multiomics Market?

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Get The Full Single Cell Multiomics Market Report:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Which Region Holds The Highest Market Share In The Single Cell Multiomics Market?

North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Single Cell Multiomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Browse Through More Reports Similar to the Global Single Cell Multiomics Market 2026, By The Business Research Company

Flow Cytometry In Oncology And Immunology Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Stem Cell Market Report

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cellular Telephone Market Report

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795